These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11341854)

  • 1. The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome.
    Bearn J; Bennett J; Martin T; Gossop M; Strang J
    Addict Biol; 2001 Apr; 6(2):147-156. PubMed ID: 11341854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
    Beswick T; Best D; Rees S; Bearn J; Gossop M; Strang J
    Addict Biol; 2003 Mar; 8(1):49-57. PubMed ID: 12745416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
    Fontaine E; Godfroid IO; Guillaume R
    Encephale; 2001; 27(2):187-93. PubMed ID: 11407272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary cortisol during opiate dependence and withdrawal.
    Bearn J; Buntwal N; Papadopoulos A; Checkley S
    Addict Biol; 2001 Apr; 6(2):157-162. PubMed ID: 11341855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lofexidine versus clonidine in rapid opiate detoxification.
    Gerra G; Zaimovic A; Giusti F; Di Gennaro C; Zambelli U; Gardini S; Delsignore R
    J Subst Abuse Treat; 2001 Jul; 21(1):11-7. PubMed ID: 11516922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Induced detoxification treatment" of opiate dependent patients--a new therapy concept].
    Loimer N; Presslich O; Lenz K; Pfersmann D; Schmid R; Fodor G; Aschauer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):451-4. PubMed ID: 2763565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms.
    Shi J; Xu GZ; Liu TT; Wang X; Shen LY; Li J; Hao W; Chen HX; Li SX; Lu L
    Am J Drug Alcohol Abuse; 2008; 34(6):792-800. PubMed ID: 19016185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.
    Strang J; Bearn J; Gossop M
    Am J Addict; 1999; 8(4):337-48. PubMed ID: 10598217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of patients with moderately severe methadone dependence onto buprenorphine.
    Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
    Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
    de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M
    Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anaesthetic agents in interference of naloxone-induced opiate-withdrawal are dose-dependent in opiate-dependent rats.
    Streel E; Dan B; Antoniali V; Clement B; Campanella S; Hanak C; Vanderlinden P; Pelc I; Verbanck P
    Life Sci; 2005 Jun; 77(6):650-5. PubMed ID: 15921996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lofexidine for opiate detoxification.
    Bearn J
    Acta Neuropsychiatr; 2004 Oct; 16(5):239-45. PubMed ID: 26984436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.